Introduction: Currently, there is no efficient vaccine available against clinical malaria.
However, continuous efforts have been committed to develop powerful antimalarial vaccine …

Background Acanthamoebiasis is most often found in patients with immune deficiency, with
infections facilitated by the intake of immunosuppressive drugs. The host immune response …

Malaria is a serious disease and is one of the most alarming public health issues.
Plasmodium is being resistant to various antimalarials including Chloroquine (CQ) which …

Liposomes loaded with GPI-anchored proteins induce a strong and effective response
against protozoan pathogens when immunized in mice. On the basis of results using …

Arsenic exposure has been linked to an impaired immune response and inflammation. Our
study investigated the effects of sodium arsenite on host immune response and vascular …

Drug Development for Malaria Provides readers with first-hand advice for the development
of novel antimalarial drugs This book provides a systematic overview of antimalarial drug …

The present study examined the effect of pure TLR7 agonistic 1‐benzyl‐2‐butyl‐1 H‐
imidazo [4, 5‐c] quinolin‐4‐amine (BBIQ) as an adjuvant along with the blood stage fraction …

Cerebral malaria (CM) is a fatal complication caused by Plasmodium falciparum in humans
claiming two million lives annually. The pathogenesis of this disease yet remains partially …

The present study demonstrates the alterations in the frequencies of helper, cytotoxic and
suppressor T cells in blood of P. berghei infected and TPA immunized rodent host towards …